Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Somberg

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
American Journal of Therapeutics|May 11, 2004
Obesity therapeutics in the shadows: editorialJohn Somberg
American Journal of Therapeutics|March 5, 2004
Who is teaching pharmacologyJohn Somberg
Cardiology Research|February 25, 2022
Heart Failure Research and PolypharmacyJohn Somberg
American Journal of Therapeutics|May 19, 2010
Composite end points, black box warnings, and allegations of biasJohn Somberg
American Journal of Therapeutics|May 21, 2009
Supporting therapeutic innovationJohn Somberg
American Journal of Therapeutics|November 6, 2015
Let us regulate pharmaceuticals: here we go againJohn Somberg
American Journal of Therapeutics|November 6, 2015
Signing offJohn Somberg
Cardiology Research|May 28, 2021
Sacubitril/Valsartan ConundrumJohn Somberg
American Journal of Therapeutics|March 22, 2008
FDA user fees and innovationJohn Somberg
American Journal of Therapeutics|May 13, 2014
International vs. hospital acquired infectionJohn Somberg
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
American Journal of Therapeutics|May 11, 2004
Obesity therapeutics in the shadows: editorialJohn Somberg
American Journal of Therapeutics|March 5, 2004
Who is teaching pharmacologyJohn Somberg
Cardiology Research|February 25, 2022
Heart Failure Research and PolypharmacyJohn Somberg
American Journal of Therapeutics|May 19, 2010
Composite end points, black box warnings, and allegations of biasJohn Somberg
American Journal of Therapeutics|May 21, 2009
Supporting therapeutic innovationJohn Somberg
American Journal of Therapeutics|November 6, 2015
Let us regulate pharmaceuticals: here we go againJohn Somberg
American Journal of Therapeutics|November 6, 2015
Signing offJohn Somberg
Cardiology Research|May 28, 2021
Sacubitril/Valsartan ConundrumJohn Somberg
American Journal of Therapeutics|March 22, 2008
FDA user fees and innovationJohn Somberg
American Journal of Therapeutics|May 13, 2014
International vs. hospital acquired infectionJohn Somberg
Pageof 8